HistoSonics Inc.
This article was originally published in Start Up
Executive Summary
Men who suffer from benign prostatic hyperplasia could soon have an alternative to surgery, if all goes well for HistoSonics Inc. The company is developing the Histotripsy system, an image-guided, robotic-manipulated procedure that uses ultrasound to excise and mechanically homogenize tissue without heat. HistoSonics believes its noninvasive office-based treatment option will be fast, effective, and cause fewer adverse effects than existing BPH treatments.